Target intelligence / Profile preview

Phospholipid bilayer lipid headgroups

Molecular classification
Lipid, Cell membrane component
01

Overview

Phospholipid bilayer lipid headgroups are the hydrophilic moieties of phospholipids that constitute the surface of biological membranes (Alberts et al., Molecular Biology of the Cell, 2002). These headgroups, which include choline, ethanolamine, serine, and glycerol, determine the surface charge and chemical environment of the cell, influencing the recruitment of peripheral membrane proteins and the activity of integral membrane proteins (Yeagle, The Membranes of Cells, 2016). In a therapeutic context, they serve as primary targets for membrane-active agents, particularly antimicrobial peptides and lipopeptides like polymyxins, which exploit the high density of negatively charged headgroups in bacterial membranes compared to host cells (Zavascki et al., 2007, PubMed: 17303205). Beyond infectious diseases, the spatial distribution and composition of these headgroups are altered in conditions such as cancer and apoptosis, where the externalization of phosphatidylserine serves as a signal for phagocytosis (Birge et al., 2016, PubMed: 27140554). Consequently, targeting or monitoring these headgroups is a vital strategy in drug development for anti-infectives and diagnostic imaging. Understanding the biophysical interactions at the headgroup level is essential for minimizing off-target effects like hemolysis or nephotoxicity associated with membrane-disrupting drugs (Vaara, 1992, PubMed: 1329317).

Other names
Membrane lipid headgroupsPolar headgroupsPhospholipid polar groups
02

Mechanism of action

Drugs typically interact with phospholipid headgroups through electrostatic and hydrophobic interactions, leading to membrane permeabilization, pore formation, or disruption of membrane-associated signaling pathways (Pogliano et al., 2012, PubMed: 22585460).

03

Biological functions

Membrane structural integrity (Alberts et al., 2002)Cell signaling (Yeagle, 2016)Ion permeability regulationProtein recruitmentCell-cell recognition
04

Disease associations

Bacterial infection (Zavascki et al., 2007, PubMed: 17303205)Cancer (Birge et al., 2016, PubMed: 27140554)Neurodegenerative diseaseViral infection
05

Safety considerations

Nephotoxicity (Zavascki et al., 2007, PubMed: 17303205)NeurotoxicityHemolysis (Vaara, 1992, PubMed: 1329317)Low selectivity between microbial and host membranes
06

Interacting drugs

Colistin (Polymyxin E)

5 more in the full profile.

07

Biomarkers

Phosphatidylserine exposure (Birge et al., 2016, PubMed: 27140554)Membrane lipid profile

Beyond the preview

Go deeper on Phospholipid bilayer lipid headgroups.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipid bilayer lipid headgroups.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call